市場調查報告書
商品編碼
1597121
到 2031 年亞太地區血氣和電解質分析儀市場預測 - 區域分析 - 按產品和最終用戶Asia Pacific Blood Gas and Electrolyte Analyzer Market Forecast to 2031 - Regional Analysis - by Product and End User |
2023年亞太地區血氣及電解質分析儀市值為3.0333億美元,預計2031年將達5.3184億美元;預計2023年至2031年複合年成長率為7.3%。
新產品的推出和批准推動亞太地區血氣和電解質分析儀市場
醫療保健產業的發展導致全球醫療保健提供者對血液氣體和電解質分析儀的需求增加。這種需求的增加有助於全球範圍內的新產品開發、產品發布和批准。此外,主要市場參與者都參與研發活動,以確保高效產品的創新和開發。以下是近期的一些產品發布和開發:
2023 年 7 月,西門子 Healthineers 推出了用於臨床化學和免疫分析測試的新型 Atellica CI 分析儀。該分析儀在首次亮相之前就獲得了美國食品和藥物管理局 (FDA) 的批准。目前可以在多個國際地點訪問它。 2022 年 7 月,在第 74 屆美國臨床化學協會年度科學會議和臨床實驗室博覽會 (2022 AACC) 上,EDAN Instruments, Inc. 宣布推出首款基於即時護理 (POC) 螢光的 CO- OX 血氣和化學分析系統,i20。該系統具有超過 45 個參數,從血氣到電解質再到 CO 血氧飽和度。 2021 年 9 月,Sensa Core Medical Instrumentation APAC 推出了 ST-200 CC 血液氣體分析儀 - 超智慧,適用於診所、醫院和診斷中心。該公司最先進的血氣模型是 ST-200 CC 超智慧 ABGEM 血氣分析儀。它是一種全自動、微處理器控制的電解質系統,可透過離子選擇性電極 (ISE)、阻抗 (Hct) 和電流分析 (pO2) 技術使用電流直接測量來執行動脈血氣分析和電解質測量。 2021 年 4 月,西門子健康歐盟推出了 epoc 血液分析系統,這是一種無線攜帶式設備,可在一分鐘內提供患者端結果。它透過一張室溫穩定測試卡、完整血氣和基本代謝組來測量血球比容和乳酸。它得到了對 COVID-19 應對工作的支持,因為血液檢測對於管理感染者至關重要。因此,市場參與者之間產品開發、發布和策略合作的增加可能會在未來幾年為血氣和電解質分析儀市場創造充足的機會。
亞太地區血氣及電解質分析儀市場概況
亞太地區血氣和電解質分析儀市場分為中國、日本、澳洲、印度、韓國和亞太其他地區。由於印度、澳洲和韓國等國家對腎臟和呼吸系統疾病的認知不斷提高,亞太地區的血氣和電解質分析儀市場預計將大幅成長。由於日本和中國等國家醫療器材產業的不斷發展,預計該市場還將成長。此外,預計這些國家呼吸部門的發展將推動預測期內的市場成長。
亞太地區血氣及電解質分析儀市場收入及 2031 年預測(百萬美元)
亞太地區血氣和電解質分析儀市場細分
亞太地區血氣和電解質分析儀市場按產品、最終用戶和國家/地區進行分類。
根據產品,亞太地區血氣和電解質分析儀市場分為血液氣體分析儀、電解質分析儀、組合分析儀等。組合分析儀細分市場在 2023 年佔據最大的市場佔有率。
按最終用戶分類,亞太地區血氣和電解質分析儀市場分為醫院和診所、臨床和診斷實驗室、家庭護理等。 2023 年,臨床和診斷實驗室領域佔據最大的市場佔有率。
按國家/地區分類,亞太地區血氣和電解質分析儀市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2023年,中國在亞太地區血氣和電解質分析儀市場佔有率中佔據主導地位。
Abbott Laboratories、Dalko Diagnostics Private Limited、Erba Diagnostics Mannheim GmbH、Hoffmann-La Roche Ltd、Medica Corporation、Nova Biomedical Corporation、Siemens Healthineers AG、Werfen SA、Radiometer Medical ApS 和 Sensa Core Medical Instrumentation Pvt Ltd. 是一些領先的公司在亞太地區血氣和電解質分析儀市場運作。
The Asia Pacific blood gas and electrolyte analyzer market was valued at US$ 303.33 million in 2023 and is projected to reach US$ 531.84 million by 2031; it is estimated to record a CAGR of 7.3% from 2023 to 2031.
New Product Launches and Approvals Boost Asia Pacific Blood Gas and Electrolyte Analyzer Market
The development of the healthcare industry has led to a rise in the demand for blood gas and electrolyte analyzers among healthcare providers across the world. This increased demand contributes to new product developments, product launches, and approvals on a global level. In addition, major market players are involved in research and development activities to ensure the innovation and development of efficient products. Following are a few of the recent product launches and developments:
In July 2023, Siemens Healthineers launched the new Atellica CI Analyser for clinical chemistry and immunoassay testing. The US Food and Drug Administration (FDA) permitted the analyzer before its debut. It is currently accessible in several international locations. In July 2022, at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC), EDAN Instruments, Inc. announced the launch of the first-ever point-of-care (POC) fluorescence-based CO-OX blood gas and chemistry analysis system, i20. The system has over 45 parameters, ranging from blood gases to electrolytes to CO-oximetry. In September 2021, Sensa Core Medical Instrumentation APAC launched ST-200 CC Blood Gas Analyzers - Ultra Smart for use in clinics, hospitals, and diagnostic centers. The highly advanced blood gas model from the company is the ST-200 CC Ultra Smart ABGEM blood gas analyzer. It is a fully automated, microprocessor-controlled electrolyte system that performs arterial blood gas analysis and electrolyte measurements using current direct measurement with ION selective electrode (ISE), impedance (Hct), and amperometry (pO2) technologies. In April 2021, Siemens Healthiness EU launched the epoc Blood Analysis System, a wireless, portable device that provides patient-side results in less than a minute. It measures hematocrit and lactate on a single room temperature-stable test card, complete blood gas, and a basic metabolic panel. It is aided by its support of COVID-19 response efforts, as blood gas testing is essential for managing infected individuals. Thus, an increase in product developments, launches, and strategic collaborations among market players is likely to create ample opportunities for the blood gas and electrolyte analyzers market in the coming years.
Asia Pacific Blood Gas and Electrolyte Analyzer Market Overview
The Asia Pacific blood gas and electrolyte analyzer market is segmented into China, Japan, Australia, India, South Korea, and the Rest of Asia Pacific. The blood gas and electrolyte analyzer market in Asia Pacific is expected to grow considerably owing to the rising awareness regarding kidney and respiratory diseases in countries such as India, Australia, and South Korea. The market is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, the development in the respiratory sectors across these countries is estimated to fuel the market growth during the forecast period.
Asia Pacific Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Blood Gas and Electrolyte Analyzer Market Segmentation
The Asia Pacific blood gas and electrolyte analyzer market is categorized into product, end user, and country.
Based on product, the Asia Pacific blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.
By end user, the Asia Pacific blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.
By country, the Asia Pacific blood gas and electrolyte analyzer market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific blood gas and electrolyte analyzer market share in 2023.
Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the Asia Pacific blood gas and electrolyte analyzer market.